Seguir
Carmino Antonio de Souza
Carmino Antonio de Souza
Professor Titular de Hematologia, Hemoterapia e Terapia Celular da Universidade de Campinas - Brasil
Dirección de correo verificada de unicamp.br - Página principal
Título
Citado por
Citado por
Año
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
10072012
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
ECML Carmino DeSouza
Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013
655*2013
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow …
HM Kantarjian, A Hochhaus, G Saglio, C De Souza, IW Flinn, L Stenke, ...
The lancet oncology 12 (9), 841-851, 2011
6292011
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or-intolerant chronic myeloid leukemia in accelerated phase
F Guilhot, J Apperley, DW Kim, EO Bullorsky, M Baccarani, GJ Roboz, ...
blood 109 (10), 4143-4150, 2007
5012007
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine …
Stem Cell Trialists’ Collaborative Group
Journal of clinical oncology: official journal of the American Society of …, 2005
4512005
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4352016
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
M Nucci, EJ Anaissie, F Queiroz‐Telles, CA Martins, P Trabasso, C Solza, ...
Cancer 98 (2), 315-319, 2003
3542003
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in …
JE Cortes, M Baccarani, F Guilhot, BJ Druker, S Branford, DW Kim, ...
Journal of Clinical Oncology 28 (3), 424, 2010
3452010
Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
TP Hughes, G Saglio, HM Kantarjian, F Guilhot, D Niederwieser, G Rosti, ...
Blood, The Journal of the American Society of Hematology 123 (9), 1353-1360, 2014
2922014
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's …
G Santini, L Salvagno, P Leoni, T Chisesi, C De Souza, MR Sertoli, ...
Journal of Clinical Oncology 16 (8), 2796-2802, 1998
2881998
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial
JF Apperley, JE Cortes, DW Kim, L Roy, GJ Roboz, G Rosti, EO Bullorsky, ...
Journal of clinical oncology 27 (21), 3472, 2009
2442009
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
AL Oliveira, M De Souza, VMH Carvalho-Dias, MA Ruiz, L Silla, ...
Bone marrow transplantation 39 (12), 775-781, 2007
2342007
A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies
AC Vigorito, WM Azevedo, JFC Marques, AM Azevedo, KAB Eid, ...
Bone marrow transplantation 22 (12), 1145-1151, 1998
2341998
Bosutinib versus imatinib in newly diagnosed chronic‐phase chronic myeloid leukaemia: results from the 24‐month follow‐up of the BELA trial
TH Brümmendorf, JE Cortes, CA de Souza, F Guilhot, L Duvillié, D Pavlov, ...
British journal of haematology 168 (1), 69-81, 2015
2202015
Improvement in the outcome of invasive fusariosis in the last decade
M Nucci, KA Marr, M Vehreschild, C De Souza, E Velasco, P Cappellano, ...
Clinical Microbiology and Infection 20 (6), 580-585, 2014
1912014
Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil
M Nucci, M Garnica, AB Gloria, DS Lehugeur, VCH Dias, LC Palma, ...
Clinical Microbiology and Infection 19 (8), 745-751, 2013
1722013
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
RP de Latour, H Schrezenmeier, A Bacigalupo, D Blaise, CA de Souza, ...
haematologica 97 (11), 1666, 2012
1702012
GVHD dry eyes treated with autologous serum tears
EM Rocha, FSA Pelegrino, CS De Paiva, AC Vigorito, CA De Souza
Bone marrow transplantation 25 (10), 1101-1103, 2000
1592000
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma–results of a comprehensive meta-analysis
A Greb, J Bohlius, S Trelle, D Schiefer, CA De Souza, C Gisselbrecht, ...
Cancer treatment reviews 33 (4), 338-346, 2007
1392007
Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation
JEL Visentainer, SR Lieber, LBL Persoli, AC Vigorito, FJP Aranha, ...
Experimental hematology 31 (11), 1044-1050, 2003
1292003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20